Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Michler

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|August 24, 2021
Altered expression of costimulatory molecules in dementiasStefan Busse, Franz von Hoff, Enrico Michler, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer ChromatographyMarc Pretze, Jan Wendrich, Holger Hartmann, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2017
Alterations in the Peripheral Immune System in DementiaMandy Busse, Enrico Michler, Franz von Hoff, et al.
EJNMMI Radiopharmacy and Chemistry|November 28, 2024
Lead-it-EAZY! GMP-compliant production of [<sup>212</sup>Pb]Pb-PSC-PEG<sub>2</sub>-TOCMarc Pretze, Enrico Michler, David Kästner, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Influence of the Molar Activity of <sup>203/212</sup>Pb-PSC-PEG<sub>2</sub>-TOC on Somatostatin Receptor Type 2-Binding and Cell UptakeMarc Pretze, Enrico Michler, Roswitha Runge, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 3, 2019
Dual-time-point <sup>64</sup> Cu-PSMA-617-PET/CT in patients suffering from prostate cancerSebastian Hoberück, Gerd Wunderlich, Enrico Michler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2025
[<sup>203/212</sup>Pb]Pb-VMT-α-NET as a novel theranostic agent for targeted alpha radiotherapy-first clinical experienceEnrico Michler, David Kästner, Marc Pretze, et al.
European Journal of Radiology|September 3, 2021
Spleno-aortic radiodensity ratio - A distinctive imaging feature to predict short-term outcome in critical care unitDieter Fedders, Genta Hoxha, Daniel Kaiser, et al.
Nuklearmedizin. Nuclear Medicine|August 24, 2019
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patientsSebastian Hoberück, Enrico Michler, Gerd Wunderlich, et al.
EJNMMI Research|October 19, 2021
Intraindividual comparison of [<sup>68</sup> Ga]-Ga-PSMA-11 and [<sup>18</sup>F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysisSebastian Hoberück, Steffen Löck, Angelika Borkowetz, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Archives of Psychiatry and Clinical Neuroscience|August 24, 2021
Altered expression of costimulatory molecules in dementiasStefan Busse, Franz von Hoff, Enrico Michler, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer ChromatographyMarc Pretze, Jan Wendrich, Holger Hartmann, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2017
Alterations in the Peripheral Immune System in DementiaMandy Busse, Enrico Michler, Franz von Hoff, et al.
EJNMMI Radiopharmacy and Chemistry|November 28, 2024
Lead-it-EAZY! GMP-compliant production of [<sup>212</sup>Pb]Pb-PSC-PEG<sub>2</sub>-TOCMarc Pretze, Enrico Michler, David Kästner, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Influence of the Molar Activity of <sup>203/212</sup>Pb-PSC-PEG<sub>2</sub>-TOC on Somatostatin Receptor Type 2-Binding and Cell UptakeMarc Pretze, Enrico Michler, Roswitha Runge, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 3, 2019
Dual-time-point <sup>64</sup> Cu-PSMA-617-PET/CT in patients suffering from prostate cancerSebastian Hoberück, Gerd Wunderlich, Enrico Michler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2025
[<sup>203/212</sup>Pb]Pb-VMT-α-NET as a novel theranostic agent for targeted alpha radiotherapy-first clinical experienceEnrico Michler, David Kästner, Marc Pretze, et al.
European Journal of Radiology|September 3, 2021
Spleno-aortic radiodensity ratio - A distinctive imaging feature to predict short-term outcome in critical care unitDieter Fedders, Genta Hoxha, Daniel Kaiser, et al.
Nuklearmedizin. Nuclear Medicine|August 24, 2019
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patientsSebastian Hoberück, Enrico Michler, Gerd Wunderlich, et al.
EJNMMI Research|October 19, 2021
Intraindividual comparison of [<sup>68</sup> Ga]-Ga-PSMA-11 and [<sup>18</sup>F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysisSebastian Hoberück, Steffen Löck, Angelika Borkowetz, et al.
Pageof 3